sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
7-Feb-2016 03:43
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 951-975 out of 1150.

<< < 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 > >>

Public Release: 29-Jul-2014
PLOS Medicine
Small increases in Ugandan urbanicity tied to CVD risk factors
Urban dwellers tend to have higher risk for cardiovascular diseases than people living in more rural locations. In a new study published in PLOS Medicine, Johanna Riha and colleagues have found that even within rural communities in Uganda that all lacked paved roads and running water, people living in villages with relatively more urban features were more likely to have risk factors for cardiovascular diseases such as physical inactivity, and high body mass index, even after controlling for socioeconomic status.
UK Medical Research Council

Contact: Maya Sandler

Public Release: 29-Jul-2014
PLOS Medicine
Malaria vaccine shows continued protection during 18 months of follow-up
A vaccine previously shown to reduce malaria in young infants and children reduces larger numbers of malaria cases in areas of higher malaria transmission, according to results from an ongoing clinical trial published in PLOS Medicine. The effect of vaccination diminished over time, but protection against clinical malaria remained evident 18 months after vaccination.
GSK Biologicals SA, PATH Malaria Vaccine Initiative

Contact: Maya Sandler

Public Release: 28-Jul-2014
Hepatitis C virus genotype 1 is most prevalent worldwide
In one of the largest prevalence studies to date, researchers from the UK provide national, regional, and global genotype prevalence estimates for the hepatitis C virus. Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.

Contact: Dawn Peters

Public Release: 28-Jul-2014
American Journal of Tropical Medicine and Hygiene
First controlled malaria infection trial in Africa paves way for drug and vaccine development
An international research team today reports the first-ever clinical trial demonstrating controlled malaria infection in an African nation in the modern era. The study, published online in the American Journal of Tropical Medicine and Hygiene represents a significant milestone in the search for new malaria drugs and vaccines.

Contact: Preeti Singh
Burness Communications

Public Release: 24-Jul-2014
What constitutes an effective response to the global 'diabesity' tsunami?
This text describes the enormous global efforts expended in the attempt to prevent diabetes by implementing prevention programs in even the remotest communities. Although considerable progress is being made, clearly, much more needs to done. Effective coordination of governmental and non-governmental organizations, food and agricultural industries, regional and local health authorities, the practicing and academic medical communities is required with considerable investment of financial and other resources if the 'diabesity' tsunami is to be thwarted.

Contact: Jason Lim
65-646-65775 x247
World Scientific

Public Release: 24-Jul-2014
Mechanism found for development of protective HIV antibodies
Scientists at Duke Medicine have found an immunologic mechanism that makes broadly neutralizing antibodies in people who are HIV-1 infected.
NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health

Contact: Sarah Avery
Duke University Medical Center

Public Release: 23-Jul-2014
ETH student develops filter for clean water around the world
An innovative filter makes it possible to purify water more quickly, simply and economically than ever before. The developers hope the device will soon play a big role development aid, and they are looking for investors to help them achieve this goal.

Contact: Media Releations ETH Zurich
ETH Zurich

Public Release: 21-Jul-2014
Nature Genetics
LSU's Mark Batzer contributes to Nature Genetics article on marmoset genome
LSU's Mark Batzer, Boyd Professor and Dr. Mary Lou Applewhite Distinguished Professor in Department of Biological Sciences in the College of Science, contributed to an article in the scientific journal Nature Genetics, titled 'The Common Marmoset Genome Provides Insight into Primate Biology and Evolution,' published on July 20.

Contact: Billy Gomila
Louisiana State University

Public Release: 21-Jul-2014
Open Access Journal of Contraception
Communication about female condom vital to young adults, UT Arlington researchers say
UT Arlington communication researchers examine sexual health messages aimed at young college adults about the female condom.

Contact: Bridget Lewis
University of Texas at Arlington

Public Release: 21-Jul-2014
The Lancet
Deaths and infections from HIV, tuberculosis, and malaria plummet globally
Today, fewer people are dying from HIV/AIDS, tuberculosis, and malaria, according to a new, first-of-its-kind analysis of trend data from 188 countries. The pace of decline in deaths and infections has accelerated since 2000, when the Millennium Development Goals were established to stop the spread of these diseases by 2015.

Contact: Rhonda Stewart
Institute for Health Metrics and Evaluation

Public Release: 21-Jul-2014
Proceedings of the National Academy of Sciences
Temple University researchers eliminate the HIV virus from cultured human cells for first time
The HIV-1 virus has proved to be tenacious, inserting its genome permanently into its victims' DNA, forcing patients to take a lifelong drug regimen to control the virus and prevent a fresh attack. Now, a team of Temple University School of Medicine researchers has designed a way to snip out the integrated HIV-1 genes for good.
National Institutes of Health

Contact: Jeremy Walter
Temple University Health System

Public Release: 17-Jul-2014
20th International AIDS Conference (AIDS 2014)
Biomarker discovery may lead to new HIV treatment
Further analysis of a Phase II study of therapeutic HIV vaccine candidate Vacc-4x revealed a potential biomarker associated with participants who experienced a more profound viral load reduction after receiving the vaccine. The results of this exploratory, ad hoc, subset analysis by St George's, University of London and Bionor Pharma were announced today at the AIDS 2014 Conference in Melbourne, Australia.
Bionor Pharma

Contact: David Sheon

Public Release: 17-Jul-2014
Proceedings of the National Academy of Sciences
Eradicating fatal sleeping sickness by killing off the tsetse fly
Steven L. Peck, a BYU professor of biology, has lent his expertise in understanding insect movement to help shape a UN-sanctioned eradication effort of the tsetse fly -- a creature that passes the fatal African sleeping sickness to humans, domestic animals, and wildlife. Results of the effort appear in the Proceedings of the National Academy of Sciences.
US State Department, Joint Food and Agriculture Organization of the United Nations, International Atomic Energy Agency, Department of Technical Cooperation, Directorate of Veterinary Services of Senegal, Institut Senegalais de Recerches Agricoles

Contact: Todd Hollingshead
Brigham Young University

Public Release: 16-Jul-2014
Anti-tank missile detector joins the fight against malaria
State-of-the-art military hardware could soon fight malaria, one of the most deadly diseases on the planet. Researchers at Monash University and the University of Melbourne have used an anti-tank Javelin missile detector, more commonly used in warfare to detect the enemy, in a new test to rapidly identify malaria parasites in blood.

Contact: Lucy Handford
Monash University

Public Release: 16-Jul-2014
Food Control
Preventing foodborne illness, naturally -- with cinnamon
Cinnamomum cassia oil was shown to be effective as a natural antibacterial agent against several strains of Shiga toxin-producing Escherichia coli, known to the US Centers for Disease Control and Prevention as 'non-O157 STEC'. The study results add to a body of knowledge that will help improve food safety and reduce or eliminate cases of food poisoning and related deaths.

Contact: Meijun Zhu
Washington State University

Public Release: 15-Jul-2014
New assay to spot fake malaria drugs could save thousands of lives
Chemists have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine -- an enormous and deadly problem in the developing world. If widely used it could help save hundreds of thousands of lives.

Contact: Vincent Remcho
Oregon State University

Public Release: 15-Jul-2014
Nature Reviews Cardiology
Cardiac patients underserved globally due to lack of rehab programs: York University researcher
The article, Global availability of cardiac rehabilitation, published online at Nature Reviews Cardiology, indicates that while 68 per cent of high-income countries have cardiac rehabilitation, only 23 per cent of low-income and middle-income countries do, despite the fact that 80 per cent of deaths from heart disease occur in these countries.

Contact: Gloria Suhasini
416-736-2100 x22094
York University

Public Release: 15-Jul-2014
PLOS Medicine
Rollout strategy for diagnostic test in India may impact TB
Xpert MTB/RIF, a recently implemented tuberculosis (TB) test, has the potential to control the TB epidemic in India, but only if the current, narrow, implementation strategy is replaced by a more ambitious one that is better funded, also includes the private sector, and better referral networks are developed between public and private sectors, according to new research published in this week's PLOS Medicine.
Bill & Melinda Gates Foundation

Contact: Maya Sandler

Public Release: 14-Jul-2014
Emerging Infectious Diseases
Sierra Leone samples: Ebola evidence in West Africa in 2006
Analysis of clinical samples from suspected Lassa fever cases in Sierra Leone showed that about two-thirds of the patients had been exposed to other emerging diseases, and nearly nine percent tested positive for Ebola virus. The study, authored by USAMRIID and published in this month's edition of Emerging Infectious Diseases, demonstrates that Ebola virus has been circulating in the region since at least 2006 -- well before the current outbreak.
Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System, US Department of Defense Cooperative Biological Engagement Program

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 10-Jul-2014
The Lancet
Injected vaccine could help eradicate polio
Re-introducing a type of polio vaccine that fell out of favor in the 1960s could hasten eradication of the disease, according to new research.
Bill & Melinda Gates Foundation

Contact: Sam Wong
Imperial College London

Public Release: 9-Jul-2014
Cell Host & Microbe
The 'yin and yang' of malaria parasite development
'Herculean study' into malaria parasite development is completed -- bringing scientists closer to disrupting the life-cycle of this highly efficient parasite.
Medical Research Council

Contact: Lindsay Brooke
University of Nottingham

Public Release: 4-Jul-2014
64th Lindau Nobel Laureate Meeting
Conclusion of the Lindau Nobel Laureate meeting
The 64th Lindau Nobel Laureate Meeting has ended with a panel discussion entitled 'Science for the benefit of mankind' on Mainau Island, Germany, today. In the panel discussion it was repeatedly emphasised that basic research forms the essential basis for applied science and should therefore be supported equally as translational research.

Contact: Christian Schumacher
Lindau Nobel Laureate Meetings

Public Release: 4-Jul-2014
The Obstetrician & Gynaecologist
Effects of conflict on women's reproductive health need to be managed sensitively
Clinicians need to be sensitive and aware of the unique challenges of women's reproductive health needs in times of conflict, suggests a new review published today in The Obstetrician & Gynaecologist.

Contact: Nicole Weingartner

Public Release: 3-Jul-2014
Angewandte Chemie
Low-cost TB test means quicker, more reliable diagnosis for patients
A new test for tuberculosis developed at the Texas A&M Health Science Center could dramatically improve the speed and accuracy of diagnosis for one of the world's deadliest diseases, enabling health care providers to report results to patients within minutes, according to a study published this week in the journal Angewandte Chemie.
Wellcome Trust

Contact: Holly Lambert Shive
Texas A&M University Health Science Center

Public Release: 1-Jul-2014
PLOS Biology
New compound blocks 'gatekeeper' enzyme to kill malaria
Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival. The compound, called WEHI-916, is the first step toward a new class of antimalarial drugs that could cure and prevent malaria infections caused by all species of the parasite, including those resistant to existing drugs.

Contact: Alan Gill
Walter and Eliza Hall Institute

Showing releases 951-975 out of 1150.

<< < 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 > >>